Managing atherogenic dyslipidaemia and diabetic retinopathy in type 2 diabetes
Description
In this Product Explainer, Endocrinologist Prof Richard O’Brien explains the role of Fenofibrate in reducing the progression of diabetic retinopathy in patients with type 2 diabetes (5 mins).
NEXT LIVE Webcast
:
Days
:
Hours
:
Minutes
Seconds
A/Prof Samantha Hocking
Tirzepatide Compared to Semaglutide for Treatment of Obesity – Latest Evidence
A/Prof Gino Pecoraro OAM
Genitourinary Syndrome of Menopause – Mythbusting for GPs
Prof Sonia Grover
Dysmenorrhoea in Teens
Prof Paul Griffin
Winter Virus Preparations
Join us for the next free webcast for GPs and healthcare professionals
High quality lectures delivered by leading independent experts
Endocrinologist; Clinical Dean of Medicine, University of Melbourne, Austin Clinical School; Director of Graduate Programs, Melbourne Medical School; Senior Endocrinologist and Director, Lipid Service, Austin Health
